Risk Factors of Atrial Fibrillation After Cardiac Surgery

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier Régional Metz-Thionville

About this trial

Supraventricular arrhythmias complicate more than 40% of cardiac surgeries and are associated with an increased risk of bleeding, stroke, heart failure, and death. Preventing the occurrence of these arrhythmias is a major challenge. This study aims to investigate risk factors and protective factors regarding atrial fibrillation and other iatrogenic cardiac arrhythmias after cardiac surgery, particularly innovative anesthetic strategies such as stellar ganglion blockade which have been recently implemented in our center.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

age >18

having undergone a scheduled cardiac surgery in the study center

having agreed to the reuse of their hospital care data

Disqualifiers

Atrial fibrillation at the admission in hospital.

Trial population

Patients having undergone a scheduled cardiac surgery in the study center and having agreed to the reuse of their hospital care data

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Occurrence of postoperative atrial fibrillation

monitor on cardiac ECG monitoring performed during the routine cares in cardiac ICU

Time frame
from cardiac surgery (day 0) up to ICU discharge (about 3 days on average)

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: